| abstract |
The invention relates to combinations and methods for the treatment of renal and cardiovascular diseases as well as hypertension, and more particularly to combinations of kidney vasodilators and $ (a) 1-adrenergic blocking agents. ganglionic. A preferable alternative is to use atriopeptins which exert a vasodilating action in the kidneys in combination with $ (a) 1-adrenergic blocking agents for the treatment of renal and cardiovascular diseases and hypertension. The blocking agent promotes prolonged renal vasodilation and, thereby, stimulates the blood supply to the kidneys and renal functions. |